The Investigation of Clinical Application of Scaffold Electrospun by Heparin-Bonded Polycaprolactone

Duan Hongyong,Ye Lin,Guan Qiang,Yang Xiaofei,Liang Ning,Han Feng,Wang Zhenfeng,Wang Haidong,Yu Hong,Zhang Yunfeng,Ma Ming
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2018.09.017
2018-01-01
Abstract:Objective To investigate the characterization of electrospun heparin-bonded polycaprolactone (hPCL) in vitro and to evaluate the possibility of heparin-bonded polycaprolactone (PCL) as scaffold of tissue-engineered blood vessel (TEBV).Methods Heparin was bonded to PCL and PCL was electrospun to scaffold in 3mm diameter to construct hPCL scaffold.hPCL was evaluated by scanning electron microscopy (SEM) to determine the surface configuration.Contact angle of hPCL was measured to obtain the hydrophilicity.Mechanical property of hPCL was investigated.Porosity of hPCL was determined by mercury intrusion porosimetry.Activated partial thromboplastin time (APTT) of hPCL was determined in vitro.methyl thiazol tetrazolium (MTT) was used to evaluate the cytotoxicity of hPCL.HPCL were implanted subdermally to evaluate the histocompatibility.Results Scanning electron microscopy (SEM)showed the diameter of fiber of hPCL was from 0.5 μm to 10.0 μm.Static contact angle was (73.6 ± 0.7) degree.The burst pressure was (1 558.5 ± 16.3) mmHg (1 mmHg =0.133 kPa).Porosity of hPCL was 83%.APTT test showed that hPCL scaffold exhibit obvious anticoagulation in vitro.hPCL was non-toxic for cells and acceptable histocompatibility.Conclusion hPCL can be used as scaffold of TEBV.
What problem does this paper attempt to address?